In the pharmaceutical sector. evergreening is considered a range of practices applied to extend monopoly protection on existing products. Filing several patent applications related to the same active pharmaceutical ingredient (API) is one of the most common manifestations of evergreening. During the COVID-19 pandemic. https://www.diegojavierfares.com/mega-price-Houston-Texans-NFL-Side-Stripe-Training-Shorts-p6850-top-buy/